High Court Approves Clinical Trial for Puberty Blockers in Children Amid Controversy
A high court judge has allowed a clinical trial involving puberty blockers for children to proceed, dismissing a legal challenge from campaigners who argued the trial could harm participants. The trial, conducted by King's College London, aims to recruit over 220 children aged 11 to 16, starting August 1. The decision was met with opposition from individuals like Keira Bell, who previously detransitioned after taking puberty blockers, and groups like the Bayswater Group, which questioned the ethical and legal standards of the trial. King's College London defended the trial, emphasizing its careful design and approval by UK health research regulators. 
